A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...
Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.
A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...
National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...
A Port Jefferson Station man was killed on Wednesday due to a single-vehicle crash on the Northern State Parkway in Dix Hills. Police are investigating the accident, Newsday reports.
According to Newsday, the 81-year-old man was driving a Nissan Altima west in the right lane, west of Exit 42. He ...
DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...
An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.
A new study from Finland has confirmed previous findings about a link between the use of cholesterol-lowering statin drugs and higher risk of Type 2 diabetes. This study, published in the journal Diabetologia, avoided some of the limitations of earlier … Continue reading →
New Canadian research shows that cholesterol-lowering statin drugs may raise the risk of developing cataracts, a clouding of the lens of the eye. While statins such as Zocor (simvastatin), Crestor (rosuvastatin), and Lipitor (atorvastatin) protect many people from heart attack … Continue reading →
According to a study just published online in the medical journal the Lancet, cholesterol-lowering statin drugs can directly increase the risk of diabetes. While statins have previously been associated with higher rates of Type 2 diabetes, it was not clear … Continue reading →
Recently published research reports serious design flaws in many of the pharmaceutical studies involving animals that precede drug trials in humans. A research team led by pharmacologist Lisa Bero of the University of California, San Francisco, analyzed animal studies of … Continue reading →
A new study has found that statins, used to lower blood cholesterol levels, may reduce exercise benefits for overweight adults. Statins rank among the best selling drugs in the world and are typically prescribed to people with obesity, diabetes, and … Continue reading →
A recent BMJ article reviewed the connection between statin medications and kidney damage. The just-published article reviewed data from over 2 million patient records dated from 1997 to 2008, said the Drug Safety Monitor. Records originated from Canadian provinces and … Continue reading →
People who use statins to lower their cholesterol may face a higher risk of developing age-related cataracts, according to a new study that appears in the August issue of Optometry and Vision Science. According to the study, the association between … Continue reading →
Statin drugs prescribed to lower cholesterol levels are more likely to cause severe muscle injuries when taken at higher doses or when more potent forms of the drug are used. According to a ScienceDaily.com report on a new study from … Continue reading →
Cholesterol-lowering statins may leave patients fatigued, according to a new study. Statins are a class of prescription drugs used in combination with diet and exercise to lower the blood levels of low-density lipoprotein (LDL) cholesterol—so-called bad cholesterol. The research found … Continue reading →
The U.S. Food and Drug Administration (FDA) issued a warning concerning statin interactions with HIV and hepatitis C medications. The notification involved interactions between protease inhibitors and certain statin drugs, including Lipitor (Atorvastatin), Mevacor (Lovastatin), Crestor (Rosuvastatin), and Zocor (Simvastatin). … Continue reading →